Selected article for: "high affinity and Zika virus"
Author: Russo, Constanza A.; Torti, María F.; Marquez, Agostina B.; Sepúlveda, Claudia S.; Alaimo, Agustina; García, Cybele C.
Title: Antiviral bioactivity of resveratrol against Zika virus infection in human retinal pigment epithelial cells
  • Cord-id: 3b143wa1
  • Document date: 2021_7_20
    • ID: 3b143wa1
    Snippet: Resveratrol (RES) is a polyphenol with increasing interest for its inhibitory effects on a wide variety of viruses. Zika virus (ZIKV) is an arbovirus which causes a broad spectrum of ophthalmological manifestations in humans. Currently there is no certified therapy or vaccine to treat it, thus it has become a major global health threat. Retinal pigment epithelium (RPE) is highly permissive and susceptible to ZIKV. This work explored the protective effects of RES on ZIKV-infected human RPE cells.
    Document: Resveratrol (RES) is a polyphenol with increasing interest for its inhibitory effects on a wide variety of viruses. Zika virus (ZIKV) is an arbovirus which causes a broad spectrum of ophthalmological manifestations in humans. Currently there is no certified therapy or vaccine to treat it, thus it has become a major global health threat. Retinal pigment epithelium (RPE) is highly permissive and susceptible to ZIKV. This work explored the protective effects of RES on ZIKV-infected human RPE cells. RES treatment resulted in a significant reduction of infectious viral particles in infected male ARPE-19 and female hTERT-RPE1 cells. This protection was positively influenced by the action of RES on mitochondrial dynamics. Also, docking studies predicted that RES has a high affinity for two enzymes of the rate-limiting steps of pyrimidine and purine biosynthesis and viral polymerase. This evidence suggests that RES might be a potential antiviral agent to treat ZIKV-induced ocular abnormalities. [Image: see text]

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and adenosine triphosphate: 1
    • absence presence and low concentration: 1, 2, 3
    • accumulate evidence and acute respiratory syndrome: 1
    • activator complex and acute respiratory syndrome: 1, 2, 3, 4
    • activator complex and adenosine triphosphate: 1
    • active site and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and adenosine triphosphate: 1, 2, 3, 4
    • acute respiratory syndrome and adenosine triphosphate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory syndrome and location analysis: 1, 2, 3, 4